Nature News highlights: 28 October 2014

If you are unable to see the message below, click here to view.

28 October 2014       nature news alert • Read Nature's news online • Subscribe to Nature Your weekly update from Nature's global news team.               • Featured               Nature Special: The hobbit at 10 ▶       In 2004, the discovery of a tiny human-like fossil threw into question our understanding of the path of human evolution. Ten years on, we revisit the discovery of Homo floresiensis in the words of those who were there, and consider why the 'hobbit', as it became affectionately known, still presents such a challenge. You can also listen to a podcast about the find featuring two of the original team, and download a PDF collection of reporting, comment and research examining the controversy surrounding the origins of this species. Read More ▶                   • Latest News               Deepwater Horizon gunk settled far and wide ▶ 27 October 2014     Survey of deep-sea sediment helps to explain ‘missing oil’ from 2010 spill. Read More ▶             EU leaders hammer out landmark climate deal ▶ 24 October 2014     Greenhouse gas emissions to be cut by at least 40% by 2030, relative to 1990 levels. Read More ▶             A quantum world arising from many ordinary ones ▶ 24 October 2014     Radical theory proposes that interactions between classical worlds can explain some quantum phenomena. Read More ▶                 • More Stories               Ferns communicate to decide their sexes ▶ 23 October 2014     Older generations release pheromones to balance the sex ratio in youngsters. Read More ▶             Cancer cells can ‘infect’ normal neighbours ▶ 23 October 2014     Tiny RNAs shed by tumours can transform healthy cells into cancerous ones. Read More ▶             Viral-research moratorium called too broad ▶ 22 October 2014     US government ban on research into enhanced pathogens also affects flu surveillance and vaccine work. Read More ▶             The discovery of Homo floresiensis: Tales of the hobbit ▶ 22 October 2014     In 2004, researchers announced the discovery of Homo floresiensis, a small relative of modern humans that lived as recently as 18,000 years ago. The ‘hobbit’ is now considered the most important hominin fossil in a generation. Here, the scientists behind the find tell its story. Read More ▶             Oldest-known human genome sequenced ▶ 22 October 2014     DNA shows a group of modern humans roamed across Asia. Read More ▶             Hobbit mystery endures a decade on ▶ 22 October 2014     Four scientists recall the discovery of Homo floresiensis and discuss the still-open question of its place in human evolution. Read More ▶             Heavy comet traffic around young star ▶ 22 October 2014     Environment of β Pictoris echoes Solar System’s turbulent early years. Read More ▶             Fossils reveal 'beer-bellied' dinosaur ▶ 22 October 2014     Waddling Deinocheirus was almost as big as a Tyrannosaurus rex. Read More ▶             Seven days: 17–23 October 2014 ▶ 22 October 2014     The week in science: Snail discovery revives publishing spat; proposed nuclear-waste site passes key US safety evaluation; and biopharmaceutical firm AbbVie cools on US$54-billion takeover deal. Read More ▶             US suspends risky disease research ▶ 22 October 2014     Government to cease funding gain-of-function studies that make viruses more dangerous, pending a safety assessment. Read More ▶             Data bank struggles as protein imaging ups its game ▶ 22 October 2014     Hybrid methods to solve structures of molecular machines create a storage headache. Read More ▶             The invisible extinction ▶ 21 October 2014     A palaeontologist wonders whether the future fossil record will preserve evidence of animals that vanish today. Read More ▶               • Newsblog               Read up to the minute coverage of research and science policy. WHO plans for millions of doses of Ebola vaccine by 2015 US research ethics agency upholds decision on informed consent Western Australia abandons shark cull Fundamental overhaul of China’s competitive funding AstraZeneca neither confirms nor denies that it will ditch antibiotics research More than half of 2007-2012 research articles now free to read Outbreak of great quakes underscores Cascadia risk Geologists face off over Yukon frontier White House suspends enhanced pathogen research Doctor bets against traditional Chinese medicine more...                   Nature Outlook Lung Cancer Lung cancer is the mortality king of malignancy, killing 1.6 million people yearly, with a five-year survival rate under 20%. With such grim statistics in mind, researchers are examining the causes of lung cancer with the aim of creating better treatments or even preventing it.  Access the Outlook free online for six months. Produced with support from Boehringer Ingelheim and Cancer Research UK.           Nature Outlook Epilepsy Stigmatization of people with epilepsy continues in certain parts of the world and though lack of funding limits epilepsy research, new ways to treat and manage seizures are on the horizon. Access the Outlook free online. Produced with support of an independent medical education grant from Sunovion Pharmaceuticals In.         • Jobs           naturejobs.com Science jobs of the week       Assistant / Associate Professor     University of South Florida (USF)            Associate or Full Professor     Columbia University Medical Center - Department of Orthopedic Surgery            Professor and Head, School of Chemistry     Monash University            Bioinformatics Group Leader (M / F)     German Cancer Research Center (DKFZ)            Senior Research Associate     University of East Anglia (UEA)          No matter what your career stage, student, postdoc or senior scientist, you will find articles on naturejobs.com to help guide you in your science career. Keep up-to-date with the latest sector trends, vote in our reader poll and sign-up to receive the monthly Naturejobs newsletter.                   Your email address is in the Nature News Weekly Alert mailing list. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact subscriptions@nature.com For print subscription enquiries, please contact feedback@nature.com Nature Publishing Group | 75 Varick Street, 9th floor | New York | NY 10013-1917 | USA Nature Publishing Group's offices: Principal offices: London - New York - Tokyo Worldwide offices: Basingstoke - Boston - Buenos Aires - Delhi - Hong Kong - Madrid - Melbourne - Munich - Paris - San Francisco - Seoul - Washington DC Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.